News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

With Big Pharma Failing, Ackman And Novartis AG (NVS) Try A New Blueprint For Drug Companies


4/23/2014 8:11:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Yesterday in a move that returned attention to healthcare takeovers, Bill Ackman, CEO of the hedge fund Pershing Square Capital, announced a bold and unusual move by partnering with pharmaceutical company, Valeant Pharmaceuticals International VRX -0.89%, Inc. to acquire a major stake in another biotech. In this case it is Allergan AGN +0.58%, Inc., the makers of the injectable wrinkle-remover BOTOX, and several ophthalmic treatments.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES